Trade PPBT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Purple Biotech Ltd. American Depositary Shares (PPBT) is trading at US$1.73, up 3.92% today as of Aug 28, 12:43 EDT. The company has a market capitalisation of US$2.55M. Over the past 52 weeks, PPBT has traded between US$1.16 and US$22.00. On Syfe you can trade PPBT with $0 commission and add it to your watchlist.
| Previous close | US$1.66 |
|---|---|
| Market cap | US$2.55M |
| 52-week range | US$1.16 – US$22.00 |
| Volume | 16.81K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Purple Biotech Ltd. American Depositary Shares
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The oncology pipeline includes CM24, NT219, and CAPTN-3. The CM24 is a humanized monoclonal antibody that blocks CEACAM1, which supports tumor immune evasion and survival through multiple pathways. The NT219 is a dual inhibitor, novel small molecule that simultaneously targets IRS1/2 and STAT3. The CAPTN-3, a preclinical platform of conditionally activated tri-specific antibodies, which engage both T cells and NK cells to induce a strong, localized immune response within the tumor microenvironment. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
Year: 2015
Purple Biotech Says Preclinical Study Supports Advancing IM1240 to First-in-Human Trial in 2027
Jun 11, 12:24 PM · MT Newswires
Stay on top of PPBT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
